Filing Details
- Accession Number:
- 0001237899-12-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-24 16:46:15
- Reporting Period:
- 2012-02-23
- Filing Date:
- 2012-02-24
- Accepted Time:
- 2012-02-24 16:46:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225472 | M Eric Shooter | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-23 | 10,000 | $0.00 | 10,000 | No | 4 | C | Indirect | GRAT self |
Common Stock | Disposition | 2012-02-23 | 9,600 | $103.51 | 400 | No | 4 | S | Indirect | GRAT self |
Common Stock | Disposition | 2012-02-23 | 400 | $104.05 | 0 | No | 4 | S | Indirect | GRAT self |
Common Stock | Acquisiton | 2012-02-23 | 10,000 | $0.00 | 10,000 | No | 4 | C | Indirect | GRAT spouse |
Common Stock | Disposition | 2012-02-23 | 9,600 | $103.51 | 400 | No | 4 | S | Indirect | GRAT spouse |
Common Stock | Disposition | 2012-02-23 | 400 | $104.05 | 0 | No | 4 | S | Indirect | GRAT spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | GRAT self |
No | 4 | S | Indirect | GRAT self |
No | 4 | S | Indirect | GRAT self |
No | 4 | C | Indirect | GRAT spouse |
No | 4 | S | Indirect | GRAT spouse |
No | 4 | S | Indirect | GRAT spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Class A Stock | Disposition | 2012-02-23 | 10,000 | $0.00 | 10,000 | $0.00 |
Common Stock | Class A Stock | Disposition | 2012-02-23 | 10,000 | $0.00 | 10,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | No | 4 | C | Indirect | ||
10,000 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,000 | Indirect | by Trust |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Class A Stock | $0.00 | 36,911 | 36,911 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
36,911 | 36,911 | Indirect |
Footnotes
- Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events.
- Represents volume-weighted average price of sales of 9,600 shares of Company stock on February 23, 2012 at prices ranging from $103.01 to $103.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the GRAT on February 23, 2012 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on February 23, 2012 at prices ranging from $104.01 to $104.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the GRAT on February 23, 2012 at each separate price.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
- The reporting person and his spouse are co-trustees and beneficiaries of the Shooter Family Trust.